InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by Keen Nicholas, Directeur Scientifique. Officer active across 1 companies, notably BICYCLE THERAPEUTICS plc. Cumulatively, 12 reports have been logged. Total volume traded: €1.6m. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
015,000 shares0
Ordinary Shares
SEC:0001209191-22-001814·
015,000 shares0
Ordinary Shares
SEC:0001209191-22-001814:0·
€192,13315,477 shares@ €12.41410.039% mcap19.5% of flow
Ordinary Shares
SEC:0001209191-21-071008·
€192,13315,477 shares@ €12.41410.039% mcap9.8% of flow
Ordinary Shares
SEC:0001209191-21-071008:0·
€46,1881,188 shares@ €38.87870.0094% mcap4.7% of flow
Ordinary Shares
SEC:0001209191-21-059375·
€46,1881,188 shares@ €38.87870.0094% mcap2.3% of flow
Ordinary Shares
SEC:0001209191-21-059375:0·
€114,2133,000 shares@ €38.07110.023% mcap11.6% of flow
Ordinary Shares
SEC:0001209191-21-056655·
€114,2133,000 shares@ €38.07110.023% mcap5.8% of flow
Ordinary Shares
SEC:0001209191-21-056655:0·
€336,80010,000 shares@ €33.680.069% mcap34.2% of flow
Ordinary Shares
SEC:0001209191-21-054789·
€336,80010,000 shares@ €33.680.069% mcap17.1% of flow
Ordinary Shares
SEC:0001209191-21-054789:0·
€295,77510,000 shares@ €29.57750.060% mcap30.0% of flow
Ordinary Shares
SEC:0001209191-21-046997·
€295,77510,000 shares@ €29.57750.060% mcap15.0% of flow
Ordinary Shares
SEC:0001209191-21-046997:0·
12 of 12 declarations
About Keen Nicholas
Nicholas Keen is the Chief Scientific Officer at BICYCLE THERAPEUTICS plc. In this role, he oversees the company's research and development initiatives, focusing on innovation in the biotechnology field. Keen is responsible for scientific direction and strategy formulation for the development of new treatments. His scientific expertise is essential for the success of BICYCLE THERAPEUTICS.
